Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.51

-2.4%

Dec 23 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (15087)	1/4/2005 1:55:28 PM
From: Icebrg	Read Replies (1) of 52153

APPX. >>Merrill Lynch previews the event, saying in case of an outright approval they see an immediate price target of $47.71 . . In case the FDA requires additional trial(s) they see an immediate price target of $31.46. >> They seem to have a lot of computing power available at Merril's place. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next